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A B S T R A C T
Disability and effectiveness of physical therapy are highly variable following ischemic stroke due to different brain regions being
affected. Functional magnetic resonance imaging (fMRI) studies of patients in the months and years following stroke have given
some insight into how the brain recovers lost functions. Initially, new pathways are recruited to compensate for the lost region,
showing as a brighter blood oxygen-level-dependent (BOLD) signal over a larger area during a task than in healthy controls.
Subsequently, activity is reduced to baseline levels as pathways become more efficient, mimicking the process of learning
typically seen during development. Preclinical models of ischemic stroke aim to enhance understanding of the biology underlying
recovery following stroke. However, the pattern of recruitment and focusing seen in humans has not been observed in preclinical
fMRI studies that are highly variable methodologically. Resting-state fMRI studies show more consistency; however, there are still
confounding factors to address. Anesthesia and method of stroke induction are the two main sources of variability in preclinical
studies; improvements here can reduce variability and increase the intensity and reproducibility of the BOLD response detected
by fMRI. Differences in task or stimulus and differences in analysis method also present a source of variability. This review
compares clinical and preclinical fMRI studies of recovery following stroke and focuses on how refinement of preclinical models
and MRI methods may obtain more representative fMRI data in relation to human studies.
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Introduction
Cerebral ischemic stroke is one of the most common causes of
adult death or disability, accounting for 1 in 17 deaths in the
United States alone.1 Currently, the only approved drug treat-
ment for ischemic stroke is tissue plasminogen activator (tPA),
which is only effective for a subset of stroke patients and must
be administered within the first few hours to be effective. For the
majority of stroke patients, treatment tends to focus on prevent-
ing further strokes, for example, throughmodifiable risk factors,
and aiding physical recovery. Functional deficits can be im-
proved to some extent through physical therapy; however, ef-
fectiveness varies greatly between patients, and many unknown
factors influence the outcome of rehabilitation.2 A greater un-
derstanding of how functional recovery progresses and what
factors promote or impede it would benefit stroke patients.
Preclinical models of stroke have been developed with
the aim of improving treatments for, and therefore recovery
of, stroke patients. Such models have provided an invaluable
insight into the pathological mechanisms activated following
ischemic stroke, including the molecular mechanisms of
excitotoxicity, the inflammatory response, disruption of the
blood brain barrier, and spreading depolarization.3 However,
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these studies have not yet translated into successful clinical
treatments. Recovery in rodents is typically measured by a
variety of somatosensory tests, ranging from simple tests of
sensory function (forepaw reaching, raising paw in response
to movement), balance (circling motion) and strength (ability
to grip and climb), to more complicated tasks such as the
staircase test or the sticker removal test.4,5 Although there is
a limitation of being unable to measure fine motor control,5
Impairment caused by experimental stroke, and degree of
functional recovery, can be measured in terms of performance
compared to healthy controls (eg, in the sticker test or staircase
test), performance compared to prestroke values (ie, baseline),
or graded on a set scale (neurological score).5 In terms of
brain function and connectivity, recovery can be defined as
the formation of new connections in surviving neurons that
perform the function of the lost neurons.6
Functional magnetic resonance imaging (MRI), a nonin-
vasive imaging method, is commonly used in preclinical and
clinical studies to detect changes in brain activity. Functional
MRI relies on the magnetic properties of oxyhemoglobin and
deoxyhemoglobin to detect localized changes in blood flow
caused by neuronal activity (the blood oxygen-level-dependent
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[BOLD] response).7 When neurons are active, blood flow
to the region increases to meet the increased demand for
oxygen through neurovascular coupling.8 This allows activity
in response to a task or stimulus to be localized and quantified,
using the BOLD response as a proxy for neuronal activity. As
functional MRI (fMRI) does not use ionizing radiation, chem-
ical tracers, or require invasive surgery/implants, it is an ideal
method for clinical studies into neurovascular pathologies such
as stroke. However, preclinical fMRI has various limitations, in-
cluding the need for animals to be anesthetized, which impacts
upon the utility of fMRI in preclinical studies. Recent advances
have allowed the use of awake animals for fMRI scanning,9,10
but this requires extensive training of animals, which is not
always compatible with disease models and therefore the
majority of studies rely on animals being anesthetized prior to
scanning. However, many anesthetics, such as isoflurane and
halothane, diminish vascular reactivity and dampen the BOLD
response.11 The commonly used injectable anesthetics urethane
and alpha-chloralose, which do not have this effect, are toxic
and carcinogenic, with a highmortality risk after a single dose,12
and therefore can only be used in nonrecovery experiments.13,14
The use of separate groups for each time point prevents track-
ing of disease progression, and leads to much higher variability
between time points.15 To improve the methodology of pre-
clinical fMRI to allow their utility in, for example, preclinical
studies of ischemic stroke, it is relevant to consider the key
methodological developments that can be gained from clinical
stroke studies using fMRI. The ultimate aim is to gain a clear
understanding of the processes that may be involved in func-
tional brain recovery following experimental stroke to allow
mechanistic investigations that may allow the identification of
novel therapeutic targets and ultimately result in patient benefit.
Functional Imaging of Recovery Following
Ischemic Stroke in Humans
Recovery of physical or cognitive function following ischemic
stroke has been largely attributed to neuronal reorganization to
compensate for lost connections.6 Initial studies reported an in-
crease in task-related activation in the ipsilesional sensorimotor
and premotor cortex, the contralesional cerebellum, the bilat-
eral supplementary motor cortex, and the parietal cortex as an
indicator of functional recovery.16 These increases in activity
are thought to represent the disinhibition of existing neuronal
pathways,16 as other brain regions adapt to allow the patient to
relearn the processes required for normal motor function.17,18
This adaptation can include bilateral activation, with redundant
pathways across the hemispheres becoming active as regions in
the undamaged hemisphere replace lost activity in the damaged
region.19,20 Alternatively, surrounding regions can adapt to by-
pass damaged pathways. For example, if the corticospinal tract,
which connects themotor cortex withmotor neurons projecting
from the spinal cord, is damaged, alternative pathways via the
anterior limb of the spinal cord can be recruited;21 however,
this adaptation may not result in full restoration of function.
Following ischemic stroke, several studies using either fMRI
or positron emission tomography (PET) have described a clear
progression of recovery of motor function, at a single time
point poststroke, typically 3-6 months.22–27 Motor impairment
in stroke is usually confined to one side of the body, and changes
are referred to as being either contralateral (ie, opposite) or
ipsilateral (ie, same) to the side of the ischemic lesion. In terms
of comparing motor ability, these studies have displayed an in-
crease in contralesional sensorimotor cortex activation during
impaired hand movements, with a similar level of contrale-
sional activation to that seen during unimpaired hand move-
ments. Impaired hand movement also caused near symmet-
rical activation of the cerebellum22 and increased activity in
the bilateral parietal cortex, prefrontal and anterior cingulate
cortex,24 and premotor cortex.26 This suggests that a greater
degree of voluntary control from these regions compensates for
lost autonomic control from the motor cortex as motor func-
tion is relearned.24 Two of these studies22,24 were also notable
for including the first analyses of functional connectivity fol-
lowing stroke, and showed that connectivity of motor regions
in the cortex and striatum in healthy controls was confined to
separate hemispheres, while in stroke patients, this connectivity
became bilateral. However, these studies only imaged patients
at one time point, and while strength testing showed full re-
covery in patients, several reported a deficit in their fine mo-
tor abilities.22 These studies show that changes in activity and
regional Cerebral Blood Flow (rCBF) occur across both hemi-
spheres following stroke, yet longitudinal studies are required
to monitor progression in recovery.22–24
Longitudinal studies tend to begin in the first fewweeks post-
stroke and continue for several months to a year poststroke.
Initially, these studies built on the work of Nelles et al27 by
imaging patients at the acute stage (<20 days post stroke) while
still suffering from hemiparesis, with a further scan occurring,
for example, 3 weeks later,28 or up to 6 months poststroke.21
Between 2 and 5 weeks poststroke, the main change in acti-
vation patterns was a decrease in CBF response and size of
activated area in ipsilesional regions, correlating with improve-
ment in limb function.28 Thus, although previous studies us-
ing a single time point poststroke demonstrated that contrale-
sional activity following stroke contributed to compensation for
lost connections in the impaired hemisphere,22,24–26 longitudi-
nal studies suggest that this contralesional activity was only the
first stage of recovery.29 In this first stage, a reorganized mo-
tor network that formed within 24 hours of the ischemic insult
was described, allowing the damaged pathways to be bypassed
through recruitment of contralesional pathways30 or alternative
pathways in the brainstem and spinal cord.21 Reorganization of
the impaired hemisphere and restoration of activity around the
lesion was shown to be the next important stage of recovery, in
which contralesional activity supports these new, less efficient
connections while processes are relearned.2,17,29 The most com-
plete recovery, in a neurological and behavioral sense, would
be a return tomostly unilateral activity in themotor cortex, with
the center of activation shifting to accommodate the damaged
tissue, and the BOLD signal intensity returning to the same
level as the undamaged hemisphere.
Based on information gained from both short-term and long-
term assessment of recovery following stroke, it may be possi-
ble to define two distinct phases of recovery in brain activity—
recruitment and focusing.28 The recruitment phase increases
the population of available neurons to compensate for lost con-
nections, particularly supplementary cortical regions and con-
tralesional regions. For example, Ward et al19 showed in stroke
patients that activity in sensorimotor regions was negatively
correlated with outcome in subcortical stroke, and thus if the
high activity observed in the recruitment phase persisted, motor
2 Journal of Neuroimaging Vol 00 No 0 xxxx 2019
ability did not recover to prestroke levels. In patients displaying
better task performance, no significant positive correlation be-
tween task outcome and task-related sensorimotor activity was
found, showing that focusing of activity was the main indicator
of good recovery in the group. A subsequent study by the same
group18 focused on a second, smaller group of patients over a
longer time period (6 months), and found the same distribu-
tion of hyperactivation, focusing, and reorganization of motor
activity.
The connections utilized in the recruitment phase are
thought to be present but inhibited in healthy brains, which
are disinhibited following stroke.31 Models of learning in
healthy subjects suggest a similar process in which a large re-
gion is recruited, followed by focusing as pathways become
reinforced.32–34 Thus, the process of learning leaves redundant
pathways in supplementary regions that can be recruited in the
event of injury, allowing for the brain to be highly adaptive
in the event of, for example, ischemic stroke. In stroke patients
with motor deficits, this manifests as activity in the inferior pari-
etal cortex,16 a region known to be important in early stages of
motor learning and the ability to visualize a task,35 suggesting
that improved sensory processing may act to compensate for
motor deficits.
In the focusing phase, as processes are relearned, activity is
reduced toward baseline levels as connections become more
efficient, and activation in contralesional or supplementary re-
gions is reduced or eliminated.19,20,29 Reduction in activity in
the cerebellum as recovery progresses16 also correlates with
changes observed in healthy subjects learning a new motor
task.36 However, lesion size and location affect the time course
of these phases, with some patients never progressing to the
focusing phase.17
More recent studies using resting-state (RS) fMRI have iden-
tified changes in functional connectivity that correlate with re-
covery. Interhemispheric connectivity greatly reduces in the
acute stage following stroke, even in regions outside the le-
sioned area.37,38 This is thought to initially be due to the un-
damaged hemisphere influencing the damaged hemisphere, as
undamaged regions compensate for lost tissue, with connectiv-
ity becoming more balanced with recovery,18,39 fitting with the
model of increased recruitment followed by focusing derived
from task-based studies.29
RS-fMRI has certain advantages over task-based fMRI. Dif-
ferent studies may measure task performance differently, for
example, in hand grip tasks. It has been suggested that how the
maximum contractile strength is calculated, whether using the
first task as a set maximum or calculating a new maximum with
each session, which affects the target grip strength so can affect
the measured outcome.18 Hand movement tasks, for example,
flexion-extension, vary greatly in complexity, and can be ac-
tive, in which the patient performs the movement themselves,
or passive, in which the researcher moves the limb by a set
amount.14 A third task type, fine motor control, for example,
using finger-thumb opposition,19 can also vary in complexity,
which can influence the size of the active region and lateraliza-
tion of activity.38 RS-fMRI removes this factor, so greater focus
on RS-fMRI may facilitate better comparison between studies
and further understanding of recovery mechanisms that would
not be discovered through task-based fMRI.
Through the use of fMRI, the progression of brain reor-
ganization and functional recovery following ischemic stroke
has been well documented in humans. However, fMRI studies
in animal models, which are an important step in the transla-
tional pipeline for identifying novel disease targets, are in their
infancy and have a number of methodological limitations to
overcome. Rodent studies of ischemic stroke use a variety of
methods to analyze outcome including behavioral measures,
electrophysiology, structural imaging, and more recently, func-
tional imaging. Such rodent studies should ideally identify com-
parable alterations in brain function and connectivity between
rodent stroke models and human stroke patients.
Functional Imaging of Recovery Following
Ischemic Stroke in Rodents
Very few preclinical stroke recovery studies have used fMRI
as an outcome measure (summarized in Table 1),40–50 which
may be due to limitations of equipment availability, financial
cost, technical expertise, and uncertainty regarding the fMRI
protocol with regard to appropriate anesthesia. Human stroke
patients are typically awake during fMRI scanning but it is com-
mon practice for animals to be anesthetized. Thus, in rodents,
fMRI typically requires the use of an appropriate anesthetic pro-
tocol that allows for detection of a hemodynamic response and
for animals to recover so that they may be scanned at sequential
time points and/or used for additional outcome measures, such
as behavior. Because of this, preclinical fMRI studies of post-
stroke recovery have tended to use different groups of animals
for each time point,40,41,44 introducing an additional source of
variability and limiting the ability to monitor the progression of
pathology and/or recovery in brain function over time.
Initial functional MRI studies performed in rats, using non-
recovery anesthesia and invasive monitoring protocols, showed
low levels of contralesional activity in response to forepaw stim-
ulation at both 3 days and 14 days poststroke, which was not
seen in sham animals, and an initial reduction in ipsilesional
activity at 3 days, followed by a slight increase at 14 days
poststroke.40 This initial increase in contralesional activity, fol-
lowed by a decrease as ipsilesional activity is restored, is similar
to the changes seen in human stroke patients.20 However, in hu-
man studies, contralesional activity is higher at the early-stage
poststroke, and ipsilesional hyperactivity is exhibited as recov-
ery progresses,16 rather than the low levels reported in rodents.
Similar findings were reported in a subsequent study by the
same group,41 although both studies report high intersubject
variability, which was also seen when animals were exposed,
under isoflurane, to nonrecovery scans poststroke.44 Studies
using a single time point also detected contralesional activ-
ity, using Cerebral Blood Volume (CBV)-weighted or contrast-
enhanced MRI sequences.45–48 These methods, when applied
to studies of novel therapeutics with behavioral outcome mea-
sures, showed benefits of modulating pathways involved with
plasticity in the thalamus46 and the contralesional cortex48 on
outcome in the chronic phase. Single time-point studies such
as this are beneficial when performed in conjunction with lon-
gitudinal behavioral studies, in understanding how differences
in activation patters correlate with long-term behavioral out-
come. However, their ability to infer the mechanisms behind
functional recovery is limited.
Advances in poststroke MRI in rodents have been assisted
with the development of suitable anesthetic protocols for lon-
gitudinal functional studies, for example, using a subcutaneous
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Table 1. Summary of Methods and Outcome Measures of Recent Preclinical fMRI Studies of Experimental Stroke in Rats’ Study
Rat Strain/Sex/Age Longitudinal? Anesthetic Stroke Model Outcome Measures
Dijkhuizen et al40 Sprague-Dawley,
male, adult
No Alpha-chloralose Permanent
MCAO
Cerebral blood volume fMRI
(3/14 days post-MCAO),
behavior, lesion volume.
Abo et al45 Sprague-Dawley,
male, young
adult
No .5% Isoflurane,
muscle
relaxant
Photochemical Cerebral blood volume fMRI
(3 weeks poststroke, behavior).
Sauter et al43 Fischer, male, not
specified
No 2% Isoflu-
rane/Nitrous
oxide
Permanent
MCAO
CBF fMRI, lesion volume
(1/2/5/12 days post-MCAO),
apparent diffusion coefficient
(ADC). Placebo vs
neuroprotection with isradipine.
DIjkhuizen et al41 Sprague-Dawley,
male, adult
No Alpha-chloralose 2 hour MCAO CBV fMRI (1/3/14 days
post-MCAO), neurological
score, lesion volume, ADC
Markus et al46 Not specified, not
specified, 25
months
No Not specified Permanent
MCAO
CBV fMRI (8 weeks post-MCAO),
behavior, effect of novel
therapeutic
Sicard et al100 Sprague-Dawley,
male, not
specified
Yes 1% isoflurane 20 minute
MCAO
BOLD fMRI, behavior, lesion vol,
ADC (0 minutes/30 minutes/
180 minutes/1 day/7 days/
21 days post-MCAO)
Kim et al47 Sprague-Dawley,
male, adult
No Alpha-chloralose 2 hour MCAO BOLD and CBV fMRI (2 weeks
post-MCAO), lesion volume
Kim et al48 Sprague-Dawley,
male, not
specified
No Alpha-chloralose 90 minute
MCAO
BOLD and CBV fMRI (2 weeks
post-MCAO), lesion volume,
effect of IV albumin.
Weber et al42 Wistar, male, not
specified
Yes Medetomidine 1 hour MCAO BOLD fMRI, electrophysiology
(2/7/14/28/49 days
post-MCAO)
Van Meer et al43 Sprague-Dawley,
male, not
specified
No 1% isoflurane 90 minute
MCAO
RS-fMRI, manganese-enhanced
MRI
Van Meer et al49 Wistar, male, not
specified
Yes 1.8% isoflurane 90 minute
MCAO
RS-fMRI (3, 7, 21, and 70 days
post-MCAO), lesion volume,
manganese-enhanced MRI,
behavior
Van Meer et al60 Sprague-Dawley,
male, young
adult
Yes 1% isoflurane 90 minute
MCAO
RS-fMRI (3, 7, 21, 49, 70 says
post-MCAO), lesion volume,
EEG, behavior
Shih et al98 Sprague-Dawley,
male, adult
Yes 1% isoflurane 20 or 45
minute
MCAO
CBV fMRI, electrophysiology
(0/7/21 days post-MCAO)
Lake et al55 Sprague-Dawley,
male, adult
Yes Propofol Endothelin-1
injection
CBF fMRI with hypercapnic
stimulus, electrophysiology with
forepaw stimulus (7 and 21 days
post-MCAO)
Lake et al83 Sprague-Dawley,
male, adult
Yes Propofol Endothelin-1
injection
CBF fMRI with hypercapnic
stimulus (7 and 21 days
post-MCAO), effect of COX-1
inhibitor
Shim et al50 Sprague-Dawley,
not specified,
adult
No Alpha-chloralose 2 hour MCAO BOLD fMRI, RS-fMRI,
Diffusion-weighted MRI, lesion
volume (6 months post-MCAO)
infusion of medetomidine.51 A longitudinal study using this
method showed three different patterns of activity following
induction of experimental stroke via middle cerebral artery oc-
clusion (MCAO).42 All animals underwent the same MCAO
procedure; however, one group of animals showed no loss of
BOLD response to forepaw stimulation and one group showed
a complete loss of activity in the forepaw region of the ipsile-
sional somatosensory cortex (S1FL). These results suggested
that there is high variability in the effects of MCAO on the in-
jured hemisphere. Across all groups, somatosensory evoked
potential (SSEP) signals were consistent with the observed
BOLD activity, suggesting preservation of neurovascular cou-
pling. In contrast to previous studies,16,40,41 there was no
contralesional somatosensory cortex activity in response to im-
paired forepaw stimulation. Lesion volume over time correlated
with changes in BOLD and SSEP signals, with small subcorti-
cal lesions causing no significant deficit, and loss and recovery
of the BOLD response correlating with size and recovery
of the lesion.42 Thus, this tended to suggest three different
severities of stroke as a consequence of the same MCAO
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procedure—minimal damage, severe damage with recovery,
and severe damage with no recovery.42 The group exhibiting
complete loss of activity in the ipsilesional cortex contrasts with
human studies, as impaired forepaw stimulation did not evoke
contralesional activity, and there was no period of ipsilesional
hyperactivity as observed in humans.16,19,20 The variability in
lesion volume and outcome, despite all rats undergoing the
same MCAO surgery, shows an inherent problem associated
with such experimental stroke models. Although attempts are
being made to try and reduce the variability in outcome mea-
sures, such as lesion volume, associated with the MCAOmodel
of experimental stroke,52 this does emphasize the importance
of performing longitudinal fMRI studies to account for within-
group variability caused by the MCAO method, and minimiz-
ing sources of variability in the imaging protocol.
A recent study compared fMRI with local field potential
(LFP) responses, using continuous arterial spin labeling MRI
to measure the CBF response to hypercapnia under propofol
anesthesia.53 While theCBF andLFP responses in this casewere
not directly compared, as forepaw stimulation was performed
for LFP experiments while CBF responses were induced with
hypercapnia, the twomodalities did show changes in poststroke
activity resembling those observed in humans.29,54 Resting per-
fusion in the ipsilesional hemisphere showed an initial increase,
and returned to baseline at 21 days poststroke.53 Reactivity
to hypercapnia in the ipsilesional hemisphere was raised at
both time points. This was attributed to injury induced angio-
genesis, triggered following ischemia,55,56 leading to a higher
vascular density at 7 days, with excess vessels pruned back
in the following weeks. This supports fMRI data in humans
showing increased neuronal recruitment followed by focusing
of activity.29 As new pathways are recruited, additional blood
flow is required to support the increased activity, and as these
pathways become more efficient, less blood supply is needed.57
LFP data showed altered organization in the ipsilesional so-
matosensory cortex compared to the contralesional cortex. In
the undamaged hemisphere, response amplitude to stimula-
tion decreased with distance from Bregma, correlating with the
responses mapped in the cortex of healthy rats.58 Following
stroke, this correlation is lost, and as recovery progresses, the
reverse is true, with peak responses observed at the furthest dis-
tance from Bregma.53 This supports the previous data shown in
humans of reorganization, where the peak activity detected is
shifted compared to healthy controls as recovery progresses.20
In recent years, RS-fMRI has become a more common
outcome measure in both clinical and preclinical research. The
ability to examine connectivity between brain regions is benefi-
cial to the understanding of recovery following stroke, as supple-
mentary regions compensate for ischemic tissue and alternative
pathways are formed. Sources of variability related to an ex-
ternal stimulus, such as sensitization of the paw from electrode
placement, artifacts from the electrical current, or habituation
in the brain to the stimulus paradigm, are also avoided. As with
stimulus-based fMRI, there has been a mix of single time point
and longitudinal RS-fMRI studies performed.43,49,50,59 Results
of RS-fMRI studies showmore consistency than stimulus-based
fMRI, and the progression of recovery in rodent RS-fMRI
studies shows more features of the progression seen in humans.
For example, increase in recruitment in early stages followed
by focusing of activity as recovery progresses can be seen in
one study of functional connectivity, in which connectivity
between the somatosensory and motor cortices in the ipsile-
sional hemisphere is increased above baseline at 3 weeks,
before returning to baseline at 10 weeks.43 Other studies show
a correlation between improved interhemispheric functional
connectivity in the chronic phase and improved functional
connectivity,50,51,59 and this is supported by a study treating
experimental stroke with mesenchymal stem cells (MSCs), in
which MSC-treated groups show improved interhemispheric
connectivity and behavioral outcome.60 While animals are
grouped by stroke severity, it is important to note that lesion
volume or localization (ie, subcortical or subcortical + cortical)
have an impact on outcome,49,59 with animals exhibiting lesions
covering both cortical and subcortical regions not showing the
recruitment and focusing pattern.43 This further supports the
need for stroke studies to group animals according to stroke
severity, to account for variability and allow therapeutic studies
to investigate different treatments to fit the severity of the lesion.
While rodent fMRI studies have begun to show important
insights into recovery of brain function following experimental
stroke, the limited number of studies and the methodological
variations between studies make comparisons difficult. How-
ever, the additional use of more invasive techniques such as
electrophysiology, which typically cannot be used in humans,
does allow parameters to be measured in rats that cannot be
measured in humans. For example, this may allow insights into
which aspects of recovery are neuronal and which aspects are
vascular.53 If preclinical studies using disease models wish to
focus on measuring recovery, then improvements in preclini-
cal imaging methodology may allow more consistent measures
of functional recovery that correlate with those seen in human
imaging studies.
Methodological Considerations Relevant to
Preclinical Stroke Imaging
Several factors are important to consider in relation to the
sources of inconsistencies between preclinical stroke imaging
studies and trying to improve correlation with clinical studies.
The first is whether a study uses several groups of animals at in-
dividual time points or conducts longitudinal analyses. In recent
years, longitudinal studies have begun to emerge, thus reducing
variation between time points, allowing progression in individ-
ual animals to be tracked, and reducing the overall number of
animals needed.42,43 Although appearing advantageous, there
are methodological limitations to consider for longitudinal stud-
ies as they require multiple anesthetic use that may cause safety
and ethical concerns. In addition, an anesthetic protocol, or re-
liable training method if using awake animals, needs to result
in minimum impairment of the BOLD signal so that changes
detected are a true representation of neurological activity and
neurovascular coupling. In addition, the method of stroke in-
duction is important, in order to ensure sufficient damage to
impair function, while trying to minimize the impact in terms
of welfare. Ethical concerns may arise when considering the
impact of repetitive scanning on the cumulative severity an in-
dividual animal is exposed to over their lifetime and ethical
guidance is likely to vary between institutions and countries.
Recently published guidelines suggest methods in which vari-
ability can be reduced and welfare improved.61 Following these
guidelines, in conjunction with the Animal Research: Reporting
of In Vivo Experiments (ARRIVE) guidelines on reporting in
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animal experiments,62 it would be beneficial for animal welfare,
experimental outcomes and analysis, and reproducibility. The
ARRIVE guidelines aim to standardize methods of reporting
to cover aspects of animal work not previously reported. This
includes a more detailed description of study design, and the
reasons behind choices such as surgical method or anesthetic
agent, which would be beneficial to attempts to standardize
methods across different groups. Reporting of housing and hus-
bandry conditions, welfare concerns that arose and how they
were dealt with, additional details of procedures such as time
and location, and animal health measures such as weight and
diet prior to procedures may also aid in identifying sources
of variability. The IMPROVE guidelines suggest a number of
improvements to housing procedures specifically for the wel-
fare of pre- and poststroke animals, and implementing these
changes may mitigate sources of variability related to animal
health prestroke,61 and reporting these methods can lead to
identification of new environmental risk factors to study.
Another issue that relates both to animal welfare and sci-
entific outcome is in the timing of experimental work, and in
balancing a minimized impact on animal welfare with a robust
model of stroke progression. Factors to consider include the age
at which experimental stroke is performed, housing procedures
following stroke, the timing of any intervention, or the timing of
behavioral and MRI experiments.61 In humans, age of onset is
a major determinant of recovery following stroke, and stroke is
most common in old age.63 In rodent studies, however, rats are
generally given experimental stroke at a young age. This also
applies to models of other age-related diseases, most likely due
to the time, expense, and welfare risks of aging animals prior to
study. Improvements to animal housing and welfare for stroke
animals also have applications in aging animals, and through
applying these to ensure that animals remain healthy as they
are, older animals can be used to understand the effect of age in
preclinical stroke.61 The length of the study poststroke, and how
enrichment, imaging experiments, behavioral testing, and other
interventions are timed, is also an important factor. The time
course of recovery is heterogeneous, and in humans’ recovery,
it is often measured by the return of abilities such as fine motor
control. Human studies then tend to group patients according to
their level of this functional recovery, through performance in
a task, to account for the variable time course.16–19 Longitudinal
rodent studies, on the other hand, tend to measure progression
in fMRI and behavioral outcome measures over time, showing
a group average with high variability.42–50 Grouping animals
by behavior, or lesion volume, and then analyzing fMRI re-
sults over time would go a long way toward accounting for the
high variability observed, and in understanding the complex
interplay between structural damage, neurovascular function,
and behavioral outcome.42 This also allows for better timing of
interventions, or enriching their environment poststroke, to be
appropriate for the animals’ state of recovery.
It has also been shown that improved reperfusion following
MCAO can reduce variability in lesion size, as well as reduc-
ing mortality and being beneficial for animal welfare.52 Other
aspects of MCAO to consider include understanding the dif-
ferences between animals that may influence the severity of
the damage from MCAO. In particular, variations in the de-
gree of collateral perfusion surrounding the circle of Willis are
thought to be a major factor determining the size of an ischemic
lesion,64 and research into this variation in rodents may aid in
predicting this variability before surgery, and grouping animals
accordingly. As increasing occlusion time does increase the
chance of a larger infarct,42 studies into the range of lesion vol-
umes caused by different occlusion times in transient MCAO
can also account for variability between studies. Modifications
such as these to MCAO studies to reduce variability in, for ex-
ample, lesion size may make comparisons across studies easier
and allow the effect of lesion volume on recovery progression
to be studied further.
Another method suitable for studies of recovery is the pho-
tothrombotic model. This model uses application of a photo-
sensitive dye into the cerebral vasculature, which is activated
by a laser to triggering platelet aggregation. This gives a con-
trolled infarct size with low mortality, does not require surgery,
and allows control over the exact location of the infarct. Reper-
fusion can be triggered by a second laser.65 This model does
not produce a penumbra; however, there are variants that pro-
duce a similar effect.66 The control of size and location of the
infarct allows modeling of ischemia in less common locations
than the MCA. This model may be useful in studies of less
common forms of cerebral stroke and studies of plasticity in the
chronic phase, with fewer welfare risks than surgical methods,
at the cost of modeling the penumbra. The advantages and dis-
advantages of the various approaches used to model ischemic
stroke in rodents have been further reviewed elsewhere includ-
ing methods that do not allow reperfusion and therefore are
more suitable for neuroprotection studies rather than studies of
recovery.67
Several studies have focused on developing an appropriate
anesthetic protocol for fMRI. Urethane and alpha-chloralose
are the two most commonly used injectable anesthetics for
fMRI, and while they both allow for robust BOLD responses,
their carcinogenic effects prevent their use for longitudinal
experiments.14 For longitudinal fMRI, some studies use a con-
tinuous infusion of medetomidine. BOLD responses to forepaw
stimulation, with two sessions under medetomidine or alpha-
choralose, showed clear, reproducible changes with no signif-
icant difference between signal intensity under medetomidine
or alpha-chloralose.51 However, medetomidine does introduce
some confounding factors, as it produces a variable depth of
anesthesia.68 It has been shown that long-term anesthesia with
medetomidine causes an increase in heart rate over time, and
an increase in dose rate is required to maintain anesthesia.68
Medetomidine can also cause hypoxia, and when the method
was first described, oxygen had to be increased to 30% part way
through scans.51 The use of a low dose combined with another
sedative, such as ketamine, has been recommended instead of
medetomidine alone in scientific and veterinary settings.14,69
Additionally, in functional connectivity studies, animals show
impaired connectivity compared to the awake state or other
anesthetics, with all regions showing a reduction in correlation
coefficients, and the thalamo-cortical pathway showing com-
plete loss of activity.70
In terms of inhalational anesthetics, some recent fMRI stud-
ies report using low doses of isoflurane anesthesia.43 However,
even low doses can affect the BOLD signal, which compromises
the accuracy of results, particularly in longitudinal studies, as a
reduction in signal amplifies the effects of physiological noise
and interanimal variation.11 Long-term changes may also be
lost, for example, where hyperactivation may be observed in
the awake animal, isoflurane will reduce the maximum signal
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change that can be observed, masking this effect.71 The effect
of isoflurane on BOLD signal is quite complex with dose-
dependent effects on several different factors contributing to the
signal, for example, isoflurane reduces local cerebral glucose
utilization (LGCU) by 40-60%, while increasing resting CBF by
25-60% measured using radiolabelling methods.72 However,
BOLD signal intensity does not change linearly with dose,
instead signal intensity peaks between 2% and 2.5% isoflurane
and drops as the dose is either reduced to 1.5% or increased to
3%,73 which is thought to reflect the different effects of isoflu-
rane on arteries and microvasculature. BOLD responses are
the same in the arteries and microvasculature at 1.5% and 3%
isoflurane, but at 2-2.5%, the arterial BOLD signal is larger.73
Even .5% isoflurane showed a significant drop in evoked BOLD
signal, with one study comparing awake animals with animals
under .5% isoflurane showing a 50% decrease in BOLD signal
under .5% isoflurane, while LFP and multiunit activity signals
only decreased by 10%.71 Halothane also has similar effects on
stimulus-based BOLD signal, and is also considered unsuitable
for use in fMRI studies.74 There is evidence to suggest that
isoflurane may be suitable for RS-fMRI studies, depending on
the dose rate and regions being investigated. Cortical functional
connectivity is well preserved under isoflurane.70 However,
fluctuations in subcortical regions are impaired in a dose-
dependent manner, requiring less than 1% isoflurane for any
subcortical or thalamocortical networks to be identified.75,76
Propofol, while less commonly used than medetomidine,
isoflurane, or urethane, has been suggested as a good candi-
date for preclinical fMRI studies.70,77–79 Studies of hypercapnia
show that cerebral autoregulation and cerebrovascular reactiv-
ity are maintained under propofol while they are lost under
isoflurane.80,81 A study comparing isoflurane, medetomidine,
propofol, and urethane showed signal intensity under propo-
fol to be three times greater than under medetomidine, and a
hemodynamic response function (HRF) closer to that of the
awake state.82 Studies using arterial spin labeling have also
shown that propofol gives a clear CBF response, and com-
parison between studies by the same group using propofol
and medetomidine shows a greater baseline CBF and stimulus-
induced CBF response under propofol than medetomidine.78,79
As functional connectivity responses, cerebral autoregulation,
cerebrovascular reactivity, and the HRF under propofol are
shown to be close to that of the awake state, propofol appears
to be an ideal choice of anesthetic protocol for fMRI. However,
to date, use of propofol in disease models such as ischemic
stroke is limited to a few studies observing changes in global
CBF in response to hypercapnia.53,83
While for practical reasons, anesthetizing animals for MRI
studies has been the norm, protocols have been developed for
scanning awake animals.9,71 The benefit of this is clear, ren-
dering animals unconscious affects brain and vascular activity,
so functional responses in an anesthetized animal are different
from those in an awake animal. Similarly, if comparing hu-
man and animal studies, using anesthesia introduces a new con-
founding factor, as humans are usually awake when undergoing
scanning.When studies have compared awake and anesthetized
animals, regardless of anesthetic used, a greater signal change
and activated area were found in the awake condition, with
propofol giving the next largest BOLD signal change.71,77,84 Dif-
ferent anesthetic protocols also alter network activation,70 and
can have a variety of adverse effects on blood pressure, breath-
ing, oxygen saturation, and temperature, depending on choice
of agent and dose.14 Anaesthetizing animals does mean that
movement is minimized, thus preventing loss of image quality
and signal artifacts. It also prevents stress from the sound of the
MRI scanner, reflexive movement in response to stimulation,
and discomfort from attachment of electrodes or physiological
monitoring equipment. However, there are several problems
in implementing an awake imaging protocol in stroke studies.
Awake rodents have not, to date, been reported in functional
imaging studies following induction of stroke, or in other age-
related neurological diseasemodels. Thus, it is unclear if, or how
stroke may affect acclimatization to the scanner and the exten-
sive pretraining required. Training of rats for awake imaging is
time-consuming, with studies performing training sessions daily
for at least 2 weeks.9,10 Stroke has damaging effects on mem-
ory, spatial awareness, motor control, and stress levels, all of
which will have a detrimental effect on the habituation state
of the animals.85 Acclimatizing the animals again poststroke
would be impossible due to the animals’ welfare and time con-
straints. Thus, scanning of awake rodents in stroke studies is not
possible at the current time from a welfare perspective and a
practical perspective. Rats are known to be more sensitive to
stress after stroke,76 which may affect the restraint method, and
motor deficits may affect the rats’ ability to position themselves
appropriately during the restraint period.
While functional imaging does provide insight into changes
in activity and connectivity following stroke, other methods
are required to investigate the underlying mechanisms.
Signaling cascades triggered by spreading depolarization, for
example, severely disrupt neurovascular coupling and oxygen
metabolism, as well as influencing plasticity and neuronal
activity.86 These factors all influence the BOLD fMRI signal,
but studying these signaling mechanisms requires invasive or
ex vivo techniques. While CBV imaging can give an indication
of vascular density, studies into angiogenesis in stroke recovery
also use molecular or ex vivo techniques.87–89 Additionally,
while recruitment of unused pathways is inferred from the
changes in the BOLD signal with recovery, the mechanisms
behind disinhibition and inhibition of pathways cannot be
measured this way, and so understanding the processes influ-
encing the transition to recruitment then focusing phase would
require more invasive methods. However, in recent years,
there has been an increase in research combining MRI with
other approaches, such as optogenetic MRI,90 MRI/PET,91
or combining MRI with two-photon microscopy,92 optical
image spectroscopy,93 or calcium imaging,94 which will
allow preclinical imaging studies to look further into these
signaling and metabolic changes. Applying knowledge of
signaling mechanisms behind stroke-related neurovascular
changes to optogenetics would have value in understanding
the influence of neurovascular uncoupling on the BOLD
signal in initial stages poststroke and pathways influencing
recovery in later stages. Concurrent MRI and two-photon or
calcium imaging would give further insight into the balance
between angiogenesis and neuronal recruitment alluded to in
MRI/electrophysiology studies.53 However, these methods ei-
ther require genetically modified animals or additional surgery,
limiting their use in translational research. MRI methods, such
as angiography or oxygen 17 imaging, or more novel methods
such as functional diffusion-weighted MRI, chemical exchange
saturation transfer (CEST),95–97 are noninvasive, but require
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more development to improve resolution or to be feasible in
a clinical scanner before they can be applied to translational
research.
Conclusions and Future Directions
Functional recovery in stroke patients is reliant on mechanisms
of synaptic plasticity associated with learning. These mecha-
nisms allow new pathways to be recruited and reinforced that
circumvent damaged tissue, and thus, restoring the lost func-
tions to a degree. Clinical studies of stroke patients with motor
deficits have observed a pattern of recruitment and focusing
that determines the extent of recovery of lost functions. Unused
synapses are disinhibited around the lesion and in the contrale-
sional hemisphere, as the patients begins to use the impaired
limb again. Large regions of activity are seen on fMRI scans
during motor tasks, mimicking the process of recruitment seen
in motor learning in healthy subjects. As learning progresses,
certain pathways are reinforced and unnecessary pathways are
inhibited, and this focusing of activity represents the second
phase of recovery. Performance onmotor tasks following stroke
is correlated with which phase of recover a patient displays on
fMRI scans. Patients showing poorer motor performance are
in the recruitment phase, and some patients do not progress
past this phase.29 As motor performance returns toward pre-
stroke levels, fMRI scans display more focused activity, shifted
to accommodate the area of lost tissue.16 While these changes
can be observed in clinical studies, to understand the mecha-
nisms behind this activity and determine what factors influence
progression of recovery, a preclinical model that displays these
features is required.
While, in principle, the noninvasive nature of fMRI should
be beneficial in animal models of disease, such as ischemic
stroke, but due largely to the practical challenges of preclinical
functional imaging, there are currently only a small number
of longitudinal studies of stroke. The findings of these studies
vary greatly, due to differences in anesthetic protocol and/or
method of experimental stroke used.42,43,53,98 In addition, none
of these studies replicate the recruitment and focusing pattern
of recovery seen in human stroke patients. The requirement
for, and reliance on, anesthesia in preclinical studies probably
accounts for this lack of reproducibility between preclinical and
human studies. Increasing prevalence of RS-fMRI in preclini-
cal studies is a positive step, providing insights into effects of
stroke on the brain as a whole in addition to the effects on the
area surrounding the lesion. The lack of an external stimulus
also removes a source of variability. Greater focus on RS-fMRI
studies would also remove a major difference in methodology
between preclinical and clinical studies, in that rodents cannot
perform motor tasks during fMRI as humans can, and so ro-
dent studies must use a sensory stimulus. However, the compli-
cated interactions between different anesthetics and functional
brain networks are only recently becoming clear. Recent stud-
ies have begun to identify signaling mechanisms behind RS
fluctuations,99 and understanding of these pathways may sup-
port choice of one anesthetic over another depending on their
interactions. Understanding and minimizing these factors that
disrupt functional connectivity needs work to aid in improving
preclinical RS-fMRI studies.
Improvements to current methodology for fMRI studies
could address some of the issues identified here and improve the
ability of preclinical models of ischemic stroke to demonstrate
the same changes in brain function and connectivity seen in hu-
man stroke studies. For example, the anesthetic agent propofol,
which is common in veterinary medicine and has a minimal
effect on HRF and the BOLD response, has the potential to
reduce variability in longitudinal fMRI studies, and may allow
for the pattern of recruitment and focusing of activity to be
detected in rodents. Recent studies also suggest a lesser dis-
ruption of functional connectivity under propofol than some
other anesthetics; however, further study into the interactions
of anesthetics with functional networks would be beneficial.
Ideally, animals should be scanned in the awake state, to more
closely replicate the methods used in human studies; however,
concerns over distress caused to the animal, or whether stroke
animals can be acclimatized to conditions in the scanner may
prevent this. Thus, it is timely to consider modifications in the
methods used for anesthetized animals for fMRI scanning that
may improve the translational relevance of preclinical stroke
models.
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